Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liver disease
Marketing
Meet Madrigal, which wants to be your liver's No. 1 fan
Madrigal is aiming to accomplish what has so far proven to be impossible: to bring a fatty liver drug across the FDA finish line and onto the market.
Ben Adams
Nov 15, 2023 9:40am
Salix teams with Bellamy Young to remove the stigma around HE
Oct 9, 2023 11:00am
Mirum ponies up $445M for 2 Travere liver disease drugs
Jul 18, 2023 8:00am
Intercept still has a long road ahead with Ocaliva in NASH
May 19, 2023 5:29pm
UK's NICE signs off on Gilead's hepatitis D drug
May 15, 2023 10:15am
Liver disease misinformation rampant on TikTok: study
May 12, 2023 9:20am
